Patient Leaflet Updated 18-Sep-2023 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
Midazolam 2 mg/ml solution for injection/infusion in pre-filled syringe
midazolam
For use in adults
1. What Midazolam is and what it is used for
2. What you need to know before you are given Midazolam
3. How to use Midazolam
4. Possible side effects
5. How to store Midazolam
6. Contents of the pack and other information
Midazolam belongs to a group of medicines known as benzodiazepines. It is a short-acting medicine that is used to induce sedation (a very relaxed state of calm, drowsiness or sleep) and relieves anxiety and muscle tension.
This medicine is used for:
You must not be given Midazolam if any of the above apply to you. If you are not sure, talk to your doctor before you are given this medicine.
Administration of midazolam may depress myocardial contractility (ability of heart muscle to contract) and cause apnoea (pauses in breathing). Severe cardio respiratory adverse events have occurred on rare occasions. These have included respiratory depression, apnoea, respiratory and/or cardiac arrest. To avoid such incidents, the injection should be given slowly and the dose should be as low as possible.
Paradoxical reactions and anterograde amnesia (loss of memory for recent events) have been reported to occur with midazolam (see section 4. Possible side effects).
Talk to your doctor before you are given Midazolam, if
If any of the above apply to you, or if you are not sure, talk to your doctor or nurse before you are given Midazolam.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription and herbal medicines.
This is extremely important, as using more than one medicine at the same time can strengthen or weaken the effect of the medicines involved.
In particular, tell your doctor or nurse if you are taking any of the following medicines:
If any of the above apply to you, or if you are not sure, talk to your doctor or nurse before you are given Midazolam.
If you are going to have an anaesthetic for an operation or for dental treatment (including inhaled anaesthetics that you breathe in), it is important to tell your doctor or dentist that you have been given Midazolam.
Do not drink alcohol if you have been given Midazolam. This is because alcohol can increase the sedative effect of Midazolam and may cause problems with your breathing.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before you are given this medicine. Your doctor will decide if this medicine is suitable for you.
Midazolam may harm your unborn baby when used in early pregnancy. When high doses are administered during late pregnancy, labour or caesarean section, you might have an inhalation risk and your baby might have an irregular heartbeat, state of low muscle tone (hypotonia), feeding difficulties, a low body temperature and difficulty in breathing. With prolonged administration during late pregnancy, your baby may develop a physical dependence and risk of withdrawal symptoms after birth.
Do not breast-feed for 24 hours after being given Midazolam. This is because Midazolam may pass into your breast milk.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
This medicinal product contains 157.36 mg sodium (main component of cooking/table salt) in each pre-filled syringe. This is equivalent to 7.9% of the maximum daily dietary intake of sodium for an adult.
Midazolam should be given only by experienced healthcare professionals. It should be given in a place (hospital, clinic or surgery) equipped to monitor and support the patient’s breathing, heart and circulation (cardiovascular function) and recognise the signs of and manage the expected side effects of anaesthesia.
Your doctor will decide on a suitable dose for you. The dose you are given will depend on why you are being treated and the type of sedation needed. Your weight, age, your state of health, how you respond to Midazolam and whether other medicines are needed at the same time will also influence the dose that you are given.
If you need strong painkillers, you will be given these first and then be given Midazolam. The dose will be adjusted specially for you.
Midazolam is not recommended for use in children due to the total amount of midazolam contained in the pre-filled syringes.
Midazolam may be given to you in one of two different ways:
You should always be taken home by a responsible adult after your treatment.
Your medicine will be given to you by a doctor or nurse. If you are accidentally given too much Midazolam you may:
If you receive long term treatment with Midazolam (are given the medicine for a long time) you may:
The following effects have been seen with midazolam use, particularly in the elderly; restlessness, agitation, irritability, involuntary movements, hyperactivity, hostility, delusion, anger, aggressiveness, anxiety, nightmares, hallucinations (seeing and possibly hearing things that are not really there), psychoses (losing contact with reality), inappropriate behaviour, excitement and assault (these are also known as paradoxical reactions, which are outcomes that are opposite to the effects normally expected for the drug). If you experience these, your doctor will consider stopping Midazolam treatment.
Your doctor will reduce your dose gradually to avoid these effects happening to you.
Withdrawal symptoms:
Benzodiazepine medicines, like Midazolam, may make you dependent if used for a long time (for instance in intensive care). This means that if you stop treatment suddenly, or lower the dose too quickly, you may get withdrawal symptoms. The symptoms can include:
In severe cases of withdrawal, the following can occur: a feeling of losing contact with reality, numbness and tingling of the extremities (e.g. hands and feet), feeling sensitive to light, noise and touch.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported (frequency not known).
Life-threatening side effects are more likely to occur in adults over 60 years of age and those who already have breathing difficulties or heart problems, particularly if the injection is given too fast or at a high dose.
Not known (cannot be estimated from the available data)
Immune system problems:
Effects on behaviour:
Muscle problems:
Mental and nervous system problems:
Heart and circulation problems:
Breathing problems:
Stomach, gut and mouth problems:
Skin problems:
Injection site problems:
Injury:
General:
Elderly patients:
Patients with severe kidney disease:
If any of the side effects become serious or troublesome, or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, foil or pre-filled syringe labels after EXP. The expiry date refers to the last day of that month.
Keep the pre-filled syringe in the outer carton, in order to protect from light.
Your doctor or pharmacist is responsible for storing Midazolam. They are also responsible for disposing of any unused Midazolam correctly.
Midazolam 1 mg/ml:
Each ml of the solution for injection/infusion contains 1 mg midazolam.
Each pre-filled syringe of 50 ml contains 50 mg midazolam.
Midazolam 2 mg/ml:
Each ml of the solution for injection/infusion contains 2 mg midazolam.
Each pre-filled syringe of 50 ml contains 100 mg midazolam.
Midazolam is a clear, colourless to viscous solution for injection/infusion.
Midazolam is available in a pack containing one blister with one pre-filled syringe containing 50 ml solution for injection/infusion.
This medicinal product is authorised in the Member States of the EEA under the following names
Germany Midazolam SUN
France Midazolam SUN
Italy Midazolam SUN
Poland Midazolam SUN
Romania Midazolam SUN
Spain Midazolam SUN
United Kingdom Midazolam
This leaflet was last revised in July 2023.
V005
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
+44 (0) 208 848 5052